Thin Film Electronics ASA
Oslo, 25 March 2021
Reference is made to the announcement by Thin Film Electronics ASA (the "Company") on 20 May 2020 regarding an Extraordinary General Meeting where the shareholders resolved to issue warrants to participants in a Private Placement and Subsequent Offering of shares, and on 30 June 2020 regarding the result of the Subsequent Offering.
The Company has received further notices of exercise for a total of 58,680,765 Warrants B and has subsequently resolved to increase the Company's share capital by NOK 6,454,884.15 in connection with the issuance of shares upon said exercises. Upon registration of this share capital increase, the Company's share capital will be NOK 128,571,605.58 divided into 1,168,832,778 shares, each share having a par value of NOK 0.11.
Contact:
Ståle Bjørnstad - Investor Relations
E-mail: stale.bjornstad@thinfilmsystems.com
Phone: +47 99 16 76 72
Kevin Barber - CEO
E-mail: kevin.barber@thinfilmsystems.com
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Global Allergy and Airways Patient Platform26.10.2025 20:17:14 CET | Press release
New Global Coalition Launches to Address the Hidden Threat of RSV in Adults
ARETI International Group26.10.2025 18:41:15 CET | Press release
ARETI International Group, Headed by Igor Makarov, Partners with INEX CLUB to Support the Mayflower Gran Prix Cyprus 2025
Novartis Pharma AG26.10.2025 18:00:00 CET | Press release
Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline
mediCAD Hectec GmbH26.10.2025 12:45:00 CET | Press release
mediCAD® 8 Revolutionizes Orthopedic and Trauma Planning with Intelligent AI Integration
Novartis Pharma AG25.10.2025 17:00:00 CEST | Press release
Novartis showcases significant immunology advancements in ACR congress with new data in complex autoimmune diseases
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
